Vaccinex Inc.
1.06
0.01 (0.95%)
At close: Jan 15, 2025, 2:52 PM
1.34
25.99%
After-hours Dec 17, 2024, 07:43 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -20.25M -19.82M -22.38M -28.85M -31.86M -29.52M -18.76M -13.94M
Depreciation & Amortization 119.00K 207.00K 169.00K 307.00K 249.00K 223.00K 206.00K 178.00K
Stock-Based Compensation 474.00K 545.00K 541.00K 732.00K 447.00K 177.00K 319.00K 135.00K
Other Working Capital 583.00K -293.00K -1.26M -1.93M 31.00K -298.00K 298.00K -2.33M
Other Non-Cash Items 2.11M 677.00K 458.00K 297.00K -44.00K 308.00K 1.22M 1.57M
Deferred Income Tax n/a -677.00K -876.00K -65.00K n/a 1.91M -3.74M -9.31M
Change in Working Capital 318.00K -11.00K -3.21M -1.07M 496.00K 1.62M -627.00K 1.65M
Operating Cash Flow -17.23M -19.07M -25.30M -28.65M -30.71M -25.28M -21.39M -19.72M
Capital Expenditures -67.00K -99.00K -32.00K -290.00K -78.00K -235.00K -68.00K -793.00K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a -20.76M n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a 14.15M 6.75M n/a n/a
Other Investing Acitivies n/a n/a n/a n/a 14.15M -14.01M n/a n/a
Investing Cash Flow -67.00K -99.00K -32.00K -290.00K 14.07M -14.24M -68.00K -793.00K
Debt Repayment -74.00K -75.00K -8.54M 9.03M n/a -5.50M 3.98M 5.68M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a n/a -985.00K -744.00K n/a 9.33M 20.00M 21.36M
Financial Cash Flow 12.45M 16.98M 23.32M 36.76M 13.80M 40.95M 23.97M 16.36M
Net Cash Flow -4.86M -2.20M -2.01M 7.82M -2.84M 1.44M 2.52M -4.16M
Free Cash Flow -17.30M -19.17M -25.33M -28.94M -30.79M -25.51M -21.45M -20.51M